COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): Coronary Microvascular Physiology Pilot Substudy
Table 2
PCI characteristics, by study drug randomization.
PCI characteristics
Colchicine (n = 24)
Placebo (n = 26)
value
Access
Radial
20 (83)
21 (81)
1||
Femoral
4 (17)
5 (19)
1||
PCI artery
Left anterior descending
13 (54)
12 (46)
0.57§
Intermediate
2 (8)
0 (0)
0.23||
Left circumflex
5 (21)
6 (23)
1||
Right coronary artery
4 (17)
8 (31)
0.33||
PCI procedure duration (minutes)
55 (47–69)
62 (51–70)
0.25‡
Contrast volume (mL)
150 (120–200)
160 (120–193)
0.86‡
Total number of balloon inflations
7.0 (5.0–11.0)
6.0 (5.0–9.0)
0.86‡
Total time of balloon inflations (seconds)
66 (48–80)
69 (51–91)
0.78‡
Total stent length (mm)
18 (15–24)
23 (18–32)
0.07‡
Maximum stent diameter (mm)
3.28 (2.95–3.99)
3.33 (3.00–3.64)
0.88‡
Stent type
Drug-eluting stent
23 (96)
26 (100)
0.48||
Bare metal stent
1 (4)
0 (0)
0.48||
Pre-PCI balloon dilation
23 (96)
25 (96)
1||
Post-PCI balloon dilation
22 (92)
24 (92)
1||
Use of OCT or IVUS
0
0
PCI complications
Stent dissection
1/23 (4)
1 (4)
1||
No reflow
0
0
Values are n/N (%), mean ± SD or median (LQ-UQ), stent dissection assessed by angiography, denotes comparison between colchicine vs placebo group, † denotes independent-samples t-test, ‡ denotes Mann–Whitney-U test, § denotes Chi-squared test, and || denotes Fisher’s exact test.
